Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Adhoute

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
World Journal of Hepatology|June 10, 2017
Usefulness of the MESH score in a European hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
World Journal of Hepatology|April 8, 2015
Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Xavier Adhoute, Guillaume Penaranda, Paul Castellani, et al.
Journal of Hepatology|September 8, 2014
Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohortXavier Adhoute, Guillaume Penaranda, Jean-Pierre Bronowicki, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2014
Sofosbuvir as backbone of interferon free treatmentsMarc Bourlière, Valèrie Oules, Christelle Ansaldi, et al.
Therapeutic Advances in Gastroenterology|December 22, 2018
Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?Marc Bourlière, Olivia Pietri, Paul Castellani, et al.
Bulletin Du Cancer|March 24, 2018
[Hepatocellular carcinoma: Increase in incidence or future plague?]Jean-Luc Raoul, Judith Raimbourg, Sandrine Hiret, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
How to optimize current therapy of HCV genotype 1 infection with boceprevirMarc Bourlière, Xavier Adhoute, Astrid Wendt, et al.
Frontiers in Endocrinology|November 29, 2023
Surgical treatment of tertiary hyperparathyroidism: does one fit for all?Claudio Casella, Claudio Guarneri, Manuela Campanile, et al.
La Revue Du Praticien|April 2, 2011
[Treatment of hepatitis C]Marc Bourlière, Asma Khaloun, Paul Castellani, et al.
World Journal of Hepatology|September 21, 2020
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
World Journal of Hepatology|June 10, 2017
Usefulness of the MESH score in a European hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
World Journal of Hepatology|April 8, 2015
Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Xavier Adhoute, Guillaume Penaranda, Paul Castellani, et al.
Journal of Hepatology|September 8, 2014
Usefulness of the HKLC vs. the BCLC staging system in a European HCC cohortXavier Adhoute, Guillaume Penaranda, Jean-Pierre Bronowicki, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2014
Sofosbuvir as backbone of interferon free treatmentsMarc Bourlière, Valèrie Oules, Christelle Ansaldi, et al.
Therapeutic Advances in Gastroenterology|December 22, 2018
Sofosbuvir, velpatasvir and voxilaprevir: a new triple combination for hepatitis C virus treatment. One pill fits all? Is it the end of the road?Marc Bourlière, Olivia Pietri, Paul Castellani, et al.
Bulletin Du Cancer|March 24, 2018
[Hepatocellular carcinoma: Increase in incidence or future plague?]Jean-Luc Raoul, Judith Raimbourg, Sandrine Hiret, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
How to optimize current therapy of HCV genotype 1 infection with boceprevirMarc Bourlière, Xavier Adhoute, Astrid Wendt, et al.
Frontiers in Endocrinology|November 29, 2023
Surgical treatment of tertiary hyperparathyroidism: does one fit for all?Claudio Casella, Claudio Guarneri, Manuela Campanile, et al.
La Revue Du Praticien|April 2, 2011
[Treatment of hepatitis C]Marc Bourlière, Asma Khaloun, Paul Castellani, et al.
World Journal of Hepatology|September 21, 2020
"Six-and-twelve" score for outcome prediction of hepatocellular carcinoma following transarterial chemoembolization. In-depth analysis from a multicenter French cohortXavier Adhoute, Guillaume Pénaranda, Jean-Luc Raoul, et al.
Pageof 7